Compare Arista Networks Inc (ANET) vs CVS Health Corp (CVS) Price & Performance

Arista Networks (ANET) trades at $188.67, down 1.9% over 24 hours, with a bullish technical outlook supported by moving averages. The stock shows strong fundamentals, with revenue growing from $4.4B in 2022 to $9.0B in 2025 and a net income margin of 38.37%. Recent earnings beats and raised 2026 guidance reflect robust AI-driven demand from hyperscalers like Meta and Microsoft.

Outlook remains positive due to AI data center expansion and Ethernet market growth, but high valuation multiples (P/E 59.71) pose risks if execution falters. Analyst consensus is strongly bullish with a $252.25 price target, though insider selling and competition require monitoring for sustained gains.

CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.

The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.